Literature DB >> 7128665

Pharmacokinetic properties of noscapine.

B Dahlström, T Mellstrand, C G Löfdahl, M Johansson.   

Abstract

Noscapine was administered to five healthy volunteers in a randomized crossover design, as an intravenous infusion of 66 mg, and as an oral 150 mg dose of either rapidly dissolving tablets or a tablet containing ion exchange resin-bound noscapine. After i.v. administration, the disposition of noscapine was bi-exponential with an elimination half-life of 2.6 h; the total plasma clearance was 22 ml/min/kg and the volume of distribution (Vdarea) was 4.7 l/kg. The absolute oral bioavailability was 30%, with a 3.6-fold interindividual variation. There was no pharmacokinetic evidence to support a prolonged action of the ion exchange resin tablet.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128665     DOI: 10.1007/bf00609627

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Absorption and excretion of noscapine.

Authors:  S VEDSO
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1961

3.  The experimental production of cough in human subjects induced by citric acid aerosols; preliminary studies on the evaluation of antitussive agents.

Authors:  H A BICKERMAN; A L BARACH
Journal:  Am J Med Sci       Date:  1954-08       Impact factor: 2.378

4.  Antitussive compounds: testing methods and results.

Authors:  C A WINTER; L FLATAKER
Journal:  J Pharmacol Exp Ther       Date:  1954-09       Impact factor: 4.030

5.  Toxicity after large doses of noscapine.

Authors:  L LASAGNA; A H OWENS; B I SHNIDER; G L GOLD
Journal:  Cancer Chemother Rep       Date:  1961-12

6.  Safe reduction of the cough reflex with noscapine. A preliminary communication on a new use for an old drug.

Authors:  R E Loder
Journal:  Anaesthesia       Date:  1969-07       Impact factor: 6.955

7.  Biphasic elimination of noscapine.

Authors:  M Gibaldi; N D Weiner
Journal:  J Pharm Sci       Date:  1966-08       Impact factor: 3.534

8.  Prolonged antitussive action of a resin-bound noscapine preparation.

Authors:  O Wulff
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

9.  Kinetics of drug decomposition. Part 37. Kinetics of autoxidation of narcotine in aqueous solutions.

Authors:  E Pawelczyk; M Zajac; B Matlak
Journal:  Pol J Pharmacol Pharm       Date:  1976 Jan-Feb

10.  Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjects.

Authors:  D W Empey; L A Laitinen; G A Young; C E Bye; D T Hughes
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

View more
  24 in total

1.  Pharmacokinetics of oral noscapine.

Authors:  M O Karlsson; B Dahlström; S A Eckernäs; M Johansson; A T Alm
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.

Authors:  Mohamed O Abdalla; Prasanthi Karna; Hari Krishna Sajja; Hui Mao; Clayton Yates; Timothy Turner; Ritu Aneja
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

Review 3.  The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications.

Authors:  Padmashree C G Rida; Dillon LiVecche; Angela Ogden; Jun Zhou; Ritu Aneja
Journal:  Med Res Rev       Date:  2015-07-14       Impact factor: 12.944

4.  Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.

Authors:  Mahavir Chougule; Apurva R Patel; Pratik Sachdeva; Tanise Jackson; Mandip Singh
Journal:  Lung Cancer       Date:  2010-07-31       Impact factor: 5.705

5.  Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.

Authors:  K Ye; Y Ke; N Keshava; J Shanks; J A Kapp; R R Tekmal; J Petros; H C Joshi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

6.  Nanoparticles Based on Linear and Star-Shaped Poly(Ethylene Glycol)-Poly(ε-Caprolactone) Copolymers for the Delivery of Antitubulin Drug.

Authors:  Karim S Shalaby; Mahmoud E Soliman; Giulia Bonacucina; Marco Cespi; Giovanni F Palmieri; Omaima A Sammour; Abdelhameed A El Shamy; Lisbeth Illum; Luca Casettari
Journal:  Pharm Res       Date:  2016-05-13       Impact factor: 4.200

7.  Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.

Authors:  Seneha Santoshi; Naresh Kumar Manchukonda; Charu Suri; Manya Sharma; Balasubramanian Sridhar; Silja Joseph; Manu Lopus; Srinivas Kantevari; Iswar Baitharu; Pradeep Kumar Naik
Journal:  J Comput Aided Mol Des       Date:  2014-12-07       Impact factor: 3.686

8.  Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats.

Authors:  Anjali Priyadarshani; Krishna Chuttani; Gaurav Mittal; Aseem Bhatnagar
Journal:  J Ovarian Res       Date:  2010-04-27       Impact factor: 4.234

9.  (3R*,5'S*)-6,7-Dimeth-oxy-3-(4'-meth-oxy-6'-methyl-5',6',7',8'-tetra-hydro-1,3-dioxolo[4,5-g]isoquinolin-5'-yl)isobenzofuran-1(3H)-one (racemic α-noscapine).

Authors:  Jan von Langermann; Heike Lorenz; Oliver Boehm; Anke Flemming; Arne Bernsdorf; Martin Köckerling; Dieter Schinzer; Andreas Seidel-Morgenstern
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-10

10.  Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.

Authors:  Tanise Jackson; Mahavir B Chougule; Nkechi Ichite; Ram R Patlolla; Mandip Singh
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-13       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.